MMSI logo

MERIT MEDICAL SYSTEMS INC

MMSINASDAQ
πŸ† #1232 by market capEarnings Oct 29US Equity
$90.59β–Ό $0.52 (βˆ’0.57%)
Live
1hβ–² 0.1%
24hβ–Ό 0.6%
7dβ–² 3.9%
14dβ–² 12.1%
30dβ–² 23.5%
1yβ–² 6.9%
🏦Market Cap
$5.41B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+11.7%
Healthy
πŸ“ŠGross Margin
49.5%
Healthy
πŸ’΅FCF Margin
12.9%
Healthy
βš–οΈP/S Ratio
3.4x
Fair
Otter Score
53
Weak

Trading Snapshot

Day Range
$89.27 – $91.43
52-Week Range
$59.74 – $94.75
Volume
$2.00B
Avg Volume
$1.50B
Shares Outstanding
59.7M
Next Earnings
Aug 30, 2026

Fundamentals Snapshot

Annual Revenue
$1.51B
Last Q Revenue
$419M
P/E Ratio
37.0
P/S Ratio
3.4x
EPS (TTM)
$2.44
Dividend Yield
0.00%

Why Investors Own MMSI

  • βœ“High-growth profile β€” revenue up +38.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 42% gross margin and 30% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.51Bβ–² +37.0% YoY
Gross Margin (TTM)
42.2%β–² +3.8% YoY
Operating Income (TTM)
$556Mβ–² +37.0% YoY
Free Cash Flow (TTM)
$447Mβ–² +37.0% YoY

About MERIT MEDICAL SYSTEMS INC

Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
53/100

Analyst Price Target

β“˜
Average Target
$111.46
β–² +23.0% Upside
High Target$133.53
Low Target$85.33
Based on 34 analysts

Latest News & Updates